Sh. Bajrang All. (526981)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Low trailing P/E of 4.01 gives apparent valuation support.
• ROE of 19.48% is historically strong, though it needs to be reconciled with weak ROCE.
• Latest quarter remains profitable with ₹6 Cr net profit on ₹47 Cr sales.
• Stock trades at the top of its 52-week range, reflecting some market optimism about recovery.

Concerns

• Sales growth is deeply negative at -56.21%, and profit growth is also down -9.40%.
• Piotroski F-Score of 3/9 signals weak financial health and possible operational distress.
• Price-to-book of 3.99 against book value of ₹66.15 leaves little asset-based margin of safety.
• ROCE of 0.97% versus ROE of 19.48% suggests operating weakness and possible leverage distortions; no dividend is paid.

AI Analysis

At ₹263.80, Sh. Bajrang All. is priced like a bargain—P/E 4.01—but Benjamin Graham taught me that cheap can be a trap when quality is poor. This is an iron and steel products business, inherently cyclical, and the numbers scream stress. Sales have collapsed 56.21%, and profit still fell 9.40% despite that low base. The latest quarter's ₹47 Cr revenue and ₹6 Cr profit are small, but at least the plant seems running. Yet the Piotroski F-Score is 3 out of 9, a red flag for deteriorating financials. The gap between ROE of 19.48% and ROCE of 0.97% is deeply troubling: it suggests the high equity return is not driven by operating strength but by financial leverage or one-off distortions. With book value at ₹66.15, paying ₹263.80 means P/B of 3.99—no margin of safety on assets. Dividend yield is nil, so the small shareholder gets nothing while waiting. In a cyclical downturn, a low P/E can become even lower; earnings may normalize down, not up. I prefer businesses with predictable cash flows and strong balance sheets. Here, debt/equity is not disclosed, promoter holding is unavailable, and F-score is weak—too many unknowns for me to trust. The 52-week range shows the stock has doubled from ₹130.50 to ₹263.80; the market is already celebrating something the fundamentals do not yet confirm. This looks like a cyclical recovery speculation, not a Graham-style investment. I would need sustained sales stabilisation, evidence of real ROCE improvement, and a price closer to book value—or at least a demonstrable moat—before considering it.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer